Persistence of Ebola virus after the end of widespread transmission in Liberia: an outbreak report

The Lancet Infectious Diseases

Volumn 18, Issue 9, 2018, Pages 1015-1024

  Dokubo, Emily Kainne ^a   Wendland, Annika ^b   Mate, Suzanne E ^c   Ladner, Jason T ^c,h   Hamblion, Esther L ^b   Raftery, Philomena ^b   Blackley, David J ^a   Laney, A Scott ^a   Mahmoud, Nuha ^b   Wayne Davies, Gloria ^b   Hensley, Lisa ^d   Stavale, Eric ^d   Fakoli, Lawrence ^e   Gregory, Christopher ^a   Chen, Tai Ho ^a   Koryon, Augustine ^f   Roth Allen, Denise ^a   Mann, Jennifer ^a   Hickey, Andrew ^a   Saindon, John ^a   Badini, Mehboob ^b   Baller, April ^b   Clement, Peter ^b   Bolay, Fatorma ^e   Wapoe, Yatta ^g   Wiley, Michael R ^c   Logue, James ^d   Dighero Kemp, Bonnie ^d   Higgs, Elizabeth ^d   Gasasira, Alex ^b   Williams, Desmond E ^a   Dahn, Bernice ^g   Kateh, Francis ^g   Nyenswah, Tolbert ^e   Palacios, Gustavo ^c   Fallah, Mosoka P ^e   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e National Public Health Institute   (Liberia)

^f International Rescue Committee   (Liberia)

^g Ministry of Health   (Liberia)

^h NORTHERN ARIZONA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CASE REPORT; CHILD; CLINICAL ARTICLE; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EPIDEMIC; FATHER; HUMAN; INFANT; LIBERIA; MALE; MOTHER; NONHUMAN; PHYLOGENY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VIRUS GENOME; VIRUS TRANSMISSION; ADULT; AGED; FEMALE; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; TRANSMISSION; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; EPIDEMICS; FEMALE; HEMORRHAGIC FEVER, EBOLA; HUMANS; INFANT; LIBERIA; MALE; MIDDLE AGED;

EID: 85051709332     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(18)30417-1     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention. Ebola (Ebola virus disease): case counts. https://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/case-counts.html, Dec 27, 2017. (Accessed 27 June 2018)
2. Centers for Disease Control and Prevention. Ebola (Ebola virus disease): previous updates—2014 west Africa outbreak. https://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/previous-updates.html, March 24, 2016. (Accessed 27 June 2018)
3. Pillai, SK, Nyenswah, T, Rouse, E, et al. Developing an incident management system to support Ebola response: Liberia, July–August 2014. MMWR Morb Mortal Wkly Rep 63 (2014), 930–933.
4. Bell, BP, Damon, IK, Jernigan, DB, et al. Overview, control strategies, and lessons learned in the CDC response to the 2014–2016 Ebola epidemic. MMWR Suppl 65:suppl 3 (2016), 4–11.
5. Christie, A, Davies-Wayne, GJ, Cordier-Lassalle, T, et al. Possible sexual transmission of Ebola virus: Liberia, 2015. MMWR Morb Mortal Wkly Rep 64 (2015), 479–481.
6. Mate, SE, Kugelman, JR, Nyenswah, TG, et al. Molecular evidence of sexual transmission of Ebola virus. N Engl J Med 373 (2015), 2448–2454.
7. WHO. Ebola situation report: 13 May 2015. http://apps.who.int/ebola/current-situation/ebola-situation-report-13-may-2015. (Accessed 27 June 2018)
8. Blackley, DJ, Wiley, MR, Ladner, JT, et al. Reduced evolutionary rate in reemerged Ebola virus transmission chains. Sci Adv, 2, 2016, e1600378.
9. WHO. Ebola situation report: 9 September 2015. http://apps.who.int/ebola/current-situation/ebola-situation-report-9-september-2015. (Accessed 27 June 2018)
10. WHO. Case definition recommendations for Ebola or Marburg virus diseases. http://apps.who.int/iris/bitstream/10665/146397/1/WHO_EVD_CaseDef_14.1_eng.pdf?ua=1&ua=1, Aug 9, 2014. (Accessed 27 June 2018)
11. Wolfe, CM, Hamblion, EL, Schulte, J, et al. Ebola virus disease contact tracing activities, lessons learned and best practices during the Duport Road outbreak in Monrovia, Liberia, November 2015. PLoS Negl Trop Dis, 11, 2017, e0005597.
12. WHO. Surveillance strategy during phase 3 of the Ebola response. http://www.who.int/csr/resources/publications/ebola/surveillance-strategy-phase3/en/, Nov 5, 2015. (Accessed 27 June 2018)
13. WHO. Laboratory diagnosis of Ebola virus disease. http://apps.who.int/iris/bitstream/handle/10665/134009/WHO_EVD_GUIDANCE_LAB_14.1_eng.pdf?sequence=1, Sept 19, 2014. (Accessed 27 June 2018)
14. Joint Project Manager Medical Countermeasure Systems. Ebola Zaire (EZ1) rRT-PCR (TaqMan) Assay on ABI 7500 Fast Dx, LightCycler, and JBAIDS instruction booklet, version 3.0. https://www.fda.gov/downloads/medicaldevices/safety/emergencysituations/ucm418802.pdf, Oct 10, 2014. (Accessed 5 July 2018)
15. Cepheid Innovation. Xpert Ebola assay: instructions for use—for use under an Emergency Use Authorization (EUA) only. http://www.fda.gov/downloads/MedicalDevices/Safety/EmergencySituations/UCM439578.pdf, March, 2015. (Accessed 27 June 2018)
16. Kennedy, SB, Bolay, F, Kieh, M, et al. Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia. N Engl J Med 377 (2017), 1438–1447.
17. Kugelman, JR, Wiley, MR, Mate, S, et al. Monitoring of Ebola virus Makona evolution through establishment of advanced genomic capability in Liberia. Emerg Infect Dis 21 (2015), 1135–1143.
18. Ladner, JT, Wiley, MR, Mate, S, et al. Evolution and spread of Ebola virus in Liberia, 2014–2015. Cell Host Microbe 18 (2015), 659–669.
19. Clark, DV, Kibuuka, H, Millard, M, et al. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. Lancet Infect Dis 15 (2015), 905–912.
20. Rowe, AK, Bertolli, J, Khan, AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. J Infect Dis 179:suppl 1 (1999), S28–S35.
21. Deen, GF, Broutet, N, Xu, W, et al. Ebola RNA persistence in semen of Ebola virus disease survivors: final report. N Engl J Med 377 (2017), 1428–1437.
22. Soka, MJ, Choi, MJ, Baller, A, et al. Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data. Lancet Glob Health 4 (2016), e736–e743.
23. Sissoko, D, Keïta, M, Diallo, B, et al. Ebola virus persistence in breast milk after no reported illness: a likely source of virus transmission from mother to child. Clin Infect Dis 64 (2017), 513–516.
24. Varkey, JB, Shantha, JG, Crozier, I, et al. Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med 372 (2015), 2423–2427.
25. Jacobs, M, Rodger, A, Bell, DJ, et al. Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet 388 (2016), 498–503.
26. Diallo, B, Sissoko, D, Loman, NJ, et al. Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days. Clin Infect Dis 63 (2016), 1353–1356.
27. MacIntyre, CR, Chughtai, AA, Recurrence and reinfection: a new paradigm for the management of Ebola virus disease. Int J Infect Dis 43 (2016), 58–61.
28. Ksiazek, TG, Rollin, PE, Williams, AJ, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 179 (1999), S177–S187.
29. MacNeil, A, Reed, Z, Rollin, PE, Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus. PLoS Negl Trop Dis, 5, 2011, e1175.
30. Singh, N, Perfect, JR, Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin Infect Dis 45 (2007), 1192–1199.
31. Rodriguez, LL, De Roo, A, Guimard, Y, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 179 (1999), S170–S176.